BUCHI Encapsulator B-395 Pro User Manual
Page 63

6 Operation
63
B-395 Pro
Operation Manual, Version C
6 .14
Encapsulation protocol for alginate-PLL-alginate membranes
The Alginate-Polylysine-Alginate-membrane is a well established encapsulation system for animal cells
first described by Lim and Sun
1
.Below is a well tried protocol.
Required solutions
1.
1.5 % Alginate solution:
1.5 % low viscositiy alginate in MOPS washing-buffer
adjust pH to 7.0 at 25°C
sterile filtration through a 0.2 µm filter
2.
Polymerization solution:
10 mM MOPS (Morpholinopropanesulfonic acid)
100 mM CaCl
2
pH = 7.2 at 25°C
3.
PLL solution:
0.05 % Poly-L-lysine MG 15’000-30’000 in MOPS washing buffer
4.
MOPS washing buffer:
10 mM MOPS (Morpholinopropanesulfonic acid)
0.85 % NaCl
pH = 7.2 at 25°C
5.
0.03 % alginate solution:
2 mL of 1.5 % alginate solutio.
+ 98 mL MOPS washing-buffer.
6.
Depolymerization solution:
50 mM Na
3
-Citrate
0.45 % NaCl
10 mM MOPS
pH = 7.2 at 25°C
For one encapsulation of 12 mL polymer-product mixture the following is needed:
•
12 mL 1.5 % alginate solution (sterile filtered)
•
100 mL 0.03 % alginate solution (not sterile)
•
225 mL Polymerization solution (not sterile)
•
75 mL PLL Solution (not sterile)
•
900 mL MOPS Washing buffer (not sterile)
•
200 mL Depolymerization solution (not sterile)
1
Lim F. and Sun A.M. 1980. Microencapsulated Islets as Bioartificial Pancreas. Science 210: p.908-910.